Mesothelioma Treatment

Mesothelioma cancer is a serious disease and new patients and their families looking for treatment should seek the support and resources they will need to better understand their diagnosis and prognosis. To help with this process, we have collected the following mesothelioma treatment information which should aid patients diagnosed with mesothelioma in deciding what the best treatment is for them.

Alimta / Cisplatin

Alimta is a chemotherapy medication that is administered to mesothelioma patients intravenously. Alimta is used to treat pleural mesothelioma and is usually administered with Cisplatin, another chemotherapy drug. Both Alimta and Cisplatin are used to treat mesothelioma patients when surgery is no longer an option. Alimta is designed to block or interfere with the creation of cancer cells, targeting 3 specific enzymes that are vital in cancer cell production.

Alimta is a 3-week treatment process that runs every 21 days. During the treatment process, Cisplatin is administered for two hours approximately 30 minutes after the end of the Alimta treatment. As with other treatment methods and medications, Alimta does have side effects that include:

Nausea and vomiting are the most common side effects and affects 8 out of 10 patients, while diarrhea, mouth sores, loss of appetite, and mouth sores affect less than 25 percent of patients.

Gemzar

Gemzar is an anti-cancer chemotherapy drug and is classified as an antimetabolite. Gemzar treatments are normally administered to patients who have pancreatic cancer, non-small cell lung cancer (mesothelioma), soft-tissue sarcoma, bladder cancer, and metastatic breast cancer. Gemzar is similar to Alimta as it also blocks or interferes with the cancer cell growth process. Gemzar is given intravenously and should not to be given if a patient is also undergoing radiation therapy. Gemzar treatment dosages are dependent on a patient's general overall health, weight, height, and cancer type.

Side Effects Gemzar

Mitomycin / Mutamycin

Mitomycin is an anti-cancer drug that is classified as an antitumor antibiotic that is administered intravenously. Mitomycin is used to treat cancers of the stomach, bladder, pancreas, breast, cervical, colorectal, head and neck, and non-small cell lung cancers such as mesothelioma.

Mitomycin is a vesicant drug, which means that it is a chemical that causes extensive tissue damage and blistering, it must be administered by a well-trained physician and/or nurse in order to avoid any leaking from the veins during treatment. If any redness or swelling is seen at the IV site, contact a physician immediately. The amount in each cycle of mitomycin is determined by the physician and is based on overall health, weight, height, and type of cancer.

Mitomycin Side Effects

In order to achieve a higher level of comfort during treatment cycles, patients are recommended to:

Prior to beginning mitomycin treatments, it is important to disclose all medications taken with your physician. This will include all prescriptive medicines, as well as over-the-counter medicines. You are not to receive any immunizations without a physician's approval.

Patients should inform their physician know if they are pregnant, plan to be pregnant, or are pregnant. Breast feeding is not allowed during mitomycin treatment cycles. Patients should be aware that their immune systems will be weak and are more prone to infections when receiving any chemotherapy such as Alimta, Gemzar, or Mitomycin.

Get A FREE Mesothelioma Treatment Guide

Fill out this form and we'll send you a FREE Mesothelioma Treatment Guide.

Privacy Policy